Roivant Sciences Ltd (NASDAQ: ROIV) is 6.85% higher on its value in year-to-date trading and has touched a low of $8.73 and a high of $13.06 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ROIV stock was last observed hovering at around $11.50 in the last trading session, with the day’s loss setting it -5.09%.
Currently trading at $6.41M, the stock is 2.87% and 5.09% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 7.28 million and changing 7283804% at the moment leaves the stock 2.70% off its SMA200. ROIV registered -2.45% loss for a year compared to 6-month loss of -1.28%. The firm has a 50-day simple moving average (SMA 50) of $10.9811 and a 200-day simple moving average (SMA200) of $11.236925.
The stock witnessed a 5.48% gain in the last 1 month and extending the period to 3 months gives it a 6.56%, and is 4.15% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.33% over the week and 2.02% over the month.
Roivant Sciences Ltd (ROIV) has around 750 employees, a market worth around $7.84B and $76.19M in sales. Profit margin for the company is -225.71%. Distance from 52-week low is 32.19% and -11.60% from its 52-week high. The company has generated returns on investments over the last 12 months (-3.60%).
The EPS is expected to shrink by -397.39% this year.
Roivant Sciences Ltd (ROIV) Top Institutional Holders
409.0 institutions hold shares in Roivant Sciences Ltd (ROIV), with institutional investors hold 120.75% of the company’s shares. The shares outstanding are 695.94M, and float is at 418.04M with Short Float at 10.63%. Institutions hold 83.50% of the Float.
The top institutional shareholder in the company is SB INVESTMENT ADVISERS (UK) LTD with over 71.36 million shares valued at $754.29 million. The investor’s holdings represent 9.6983% of the ROIV Shares outstanding. As of 2024-06-30, the second largest holder is VIKING GLOBAL INVESTORS LP with 69.16 million shares valued at $730.98 million to account for 9.3985 of the shares outstanding. The other top investors are QVT FINANCIAL LP which holds 66.72 million shares representing 9.0674% and valued at over $705.23 million, while FMR LLC holds 6.3265 of the shares totaling 46.55 million with a market value of $492.05 million.
Roivant Sciences Ltd (ROIV) Insider Activity
The most recent transaction is an insider sale by Venker Eric, the company’s President & COO. SEC filings show that Venker Eric sold 100,000 shares of the company’s common stock on Jun 20 ’25 at a price of $11.45 per share for a total of $1.15 million. Following the sale, the insider now owns 1.46 million shares.
Roivant Sciences Ltd disclosed in a document filed with the SEC on Jun 20 ’25 that Ramaswamy Vivek (10% Owner) sold a total of 577,007 shares of the company’s common stock. The trade occurred on Jun 20 ’25 and was made at $11.46 per share for $6.61 million. Following the transaction, the insider now directly holds 37.28 million shares of the ROIV stock.
Still, SEC filings show that on Jun 18 ’25, Ramaswamy Vivek (10% Owner) disposed off 565,266 shares at an average price of $11.45 for $6.47 million. The insider now directly holds 37,861,115 shares of Roivant Sciences Ltd (ROIV).
